Valery Pavlov

Title: Valery Pavlov: Innovator in Nanotechnology

Introduction

Valery Pavlov is a notable inventor based in Astigarraga, Spain. He has made significant contributions to the field of nanotechnology, particularly in the development of nanocluster-antibody conjugates. His work has implications for both therapeutic and diagnostic applications.

Latest Patents

Valery Pavlov holds a patent for "Nanocluster-antibody conjugates and uses thereof." This invention provides a metallic nanocluster (NC)—antibody (Ab) conjugate, wherein the NC has an average size lower than 3 nm. The conjugate comprises one single NC, maintains the antibody's binding ability, and exhibits catalytic activity selected from peroxidase-like and photocatalytic activity. The invention also details a process for preparing the conjugate, along with compositions, kits, and uses in therapy and diagnostics. Notably, the conjugate demonstrates improved catalytic activity, enhancing the sensitivity of immunoassays.

Career Highlights

Throughout his career, Valery Pavlov has worked with esteemed organizations such as Asociación Centro de Investigación Cooperativa en Biomateriales—CIC BiomaGUNE and Fundación Tecnalia Research & Innovation. His experience in these institutions has allowed him to advance his research and contribute to the field of biomaterials and nanotechnology.

Collaborations

Valery has collaborated with several professionals in his field, including Nerea Briz Iceta and Veronica Mora Sanz. These collaborations have enriched his research and fostered innovation in his projects.

Conclusion

Valery Pavlov's work in nanotechnology, particularly with nanocluster-antibody conjugates, showcases his innovative spirit and dedication to advancing scientific knowledge. His contributions have the potential to significantly impact therapeutic and diagnostic practices.